Y-mAbs Therapeutics Inc. (YMAB)
undefined
undefined%
At close: undefined
9.43
0.64%
After-hours Dec 13, 2024, 04:00 PM EST

Y-mAbs Therapeutics Inc. Forcast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for YMAB stock have an median target of 23, with a low estimate of 17 and a high estimate of 26. The median target predicts an increase of 145.46% from the current stock price of 9.37.

Analyst Consensus: Buy
Target Low Average Median High
Price $17 $22.25 $23 $26
Change 81.43% 137.46% 145.46% 177.48%

AI Analyst Report

HC Wainwright & Co. reiterated a Buy rating on Y-m... Unlock content with Pro Subscription

Updated Nov 15, 2024

Rating Jun 24Jul 24Aug 24Sep 24Nov 24Dec 24
Strong Buy 000000
Buy 114222
Hold 000000
Sell 001000
Strong Sell 000000
Total 1 1 5 2 2 2

Financial Forecast this Year

Revenue This Year
93.29M
from 84.82M
Increased by 10.0%
Revenue Next Year
112.00M
from 93.29M
Increased by 20.0%
EPS This Year
-0.62
from -0.49
Increased by -26.5%
EPS Next Year
-0.57
from -0.62
Increased by 8.1%